Using cells derived from human pluripotent stem cells for therapeutic applications carries a risk that rare undifferentiated cells in the transplant will give rise to teratomas. Tang et al. identify a new antigen on the surface of human pluripotent cells that, combined with other antigens, enables complete depletion of teratoma-initiating cells.
- Chad Tang
- Andrew S Lee
- Micha Drukker
